Cargando…

Urotensin II Inhibits Skeletal Muscle Glucose Transport Signaling Pathways via the NADPH Oxidase Pathway

Our previous studies have demonstrated that the urotensin (UII) and its receptor are up-regulated in the skeletal muscle of mice with type II diabetes mellitus (T2DM), but the significance of UII in skeletal muscle insulin resistance remains unknown. The purpose of this study was to investigate the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Hong-Xia, Wu, Xin-Rui, Yang, Hui, Yin, Chun-Lin, Shi, Li-Jin, Wang, Xue-Jiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3792887/ https://www.ncbi.nlm.nih.gov/pubmed/24116164 http://dx.doi.org/10.1371/journal.pone.0076796

Ejemplares similares

Urotensin-II-Mediated Reactive Oxygen Species Generation via NADPH Oxidase Pathway Contributes to Hepatic Oval Cell Proliferation
por: Yu, XiaoTong, et al.
Publicado: (2015)

Decreased NADPH oxidase expression and antioxidant activity in cachectic skeletal muscle
por: Sullivan-Gunn, Melanie J., et al.
Publicado: (2011)

NADPH Oxidase 4 Contributes to Myoblast Fusion and Skeletal Muscle Regeneration
por: Youm, Tae Hyun, et al.
Publicado: (2019)

Differential Expression of NADPH Oxidases Depends on Skeletal Muscle Fiber Type in Rats
por: Loureiro, Adriano César Carneiro, et al.
Publicado: (2016)

Antagonizing urotensin receptor is a novel therapeutic strategy for glucocorticoid‐induced skeletal muscle atrophy
por: Yin, Lin, et al.
Publicado: (2022)

Skeletal Muscle NADPH Oxidase Is Increased and Triggers Stretch-Induced Damage in the mdx Mouse
por: Whitehead, Nicholas P., et al.
Publicado: (2010)

Adaptations to high-intensity interval training in skeletal muscle require NADPH oxidase 2
por: Henríquez-Olguín, Carlos, et al.
Publicado: (2019)

Urotensin II in cardiovascular regulation
por: Russell, Fraser D
Publicado: (2008)

A Novel Urotensin II Receptor Antagonist, KR-36996 Inhibits Smooth Muscle Proliferation through ERK/ROS Pathway
por: Kim, Tae-Ho, et al.
Publicado: (2017)

Sphingomyelinase promotes oxidant production and skeletal muscle contractile dysfunction through activation of NADPH oxidase
por: Loehr, James A., et al.
Publicado: (2015)

Central and Peripheral Effects of Urotensin II and Urotensin II-Related Peptides on Cardiac Baroreflex Sensitivity in Trout
por: Lancien, Frédéric, et al.
Publicado: (2017)

Natural Bioactive Compounds Targeting NADPH Oxidase Pathway in Cardiovascular Diseases
por: Sofiullah, Siti Sarah M., et al.
Publicado: (2023)

Calcitonin gene‐related peptide inhibits angiotensin II‐induced NADPH oxidase‐dependent ROS via the Src/STAT3 signalling pathway
por: Luo, Hong‐min, et al.
Publicado: (2020)

Chronic Urotensin-II Administration Improves Whole-Body Glucose Tolerance in High-Fat Diet-Fed Mice
por: Chen, Xi, et al.
Publicado: (2019)

Possible Role of NADPH Oxidase 4 in Angiotensin II-Induced Muscle Wasting in Mice
por: Kadoguchi, Tomoyasu, et al.
Publicado: (2018)

Cytosolic ROS production by NADPH oxidase 2 regulates muscle glucose uptake during exercise
por: Henríquez-Olguin, Carlos, et al.
Publicado: (2019)

Hyperglycemia Induces Neutrophil Extracellular Traps Formation Through an NADPH Oxidase-Dependent Pathway in Diabetic Retinopathy
por: Wang, Luoziyi, et al.
Publicado: (2019)

NADPH Oxidase and Neurodegeneration
por: Hernandes, Marina S, et al.
Publicado: (2012)

Inhibitory Effect of an Urotensin II Receptor Antagonist on Proinflammatory Activation Induced by Urotensin II in Human Vascular Endothelial Cells
por: Park, Sung Lyea, et al.
Publicado: (2013)

Divergent cardio-ventilatory and locomotor effects of centrally and peripherally administered urotensin II and urotensin II-related peptides in trout
por: Vanegas, Gilmer, et al.
Publicado: (2015)

Urotensin II-induced signaling involved in proliferation of vascular smooth muscle cells
por: Iglewski, Myriam, et al.
Publicado: (2010)

Increased expression of urotensin II is associated with poor prognosis in hepatocellular carcinoma
por: Liu, Dian-Gang, et al.
Publicado: (2016)

Strenuous Acute Exercise Induces Slow and Fast Twitch-Dependent NADPH Oxidase Expression in Rat Skeletal Muscle
por: Osório Alves, Juliana, et al.
Publicado: (2020)

Inhibition of the NADPH Oxidase Pathway Reduces Ferroptosis during Septic Renal Injury in Diabetic Mice
por: Yao, Weifeng, et al.
Publicado: (2022)

Urotensin II Promotes Atherosclerosis in Cholesterol-Fed Rabbits
por: Li, Yafeng, et al.
Publicado: (2014)

Conserved role of the urotensin II receptor 4 signalling pathway to control body straightness in a tetrapod
por: Alejevski, Faredin, et al.
Publicado: (2021)

Salidroside and isorhamnetin attenuate urotensin II-induced inflammatory response in vivo and in vitro: Involvement in regulating the RhoA/ROCK II pathway
por: Wang, Chenjing, et al.
Publicado: (2021)

NADPH Oxidases and Their Role in Atherosclerosis
por: Poznyak, Anastasia V., et al.
Publicado: (2020)

NADPH Oxidases in Pain Processing
por: Kallenborn-Gerhardt, Wiebke, et al.
Publicado: (2022)

NADPH Oxidases in Aortic Aneurysms
por: Salmon, Morgan
Publicado: (2022)

Inhibition of NADPH Oxidases Prevents the Development of Osteoarthritis
por: Han, Jin, et al.
Publicado: (2022)

Urotensin II receptor as a potential biomarker for the prognosis of hepatocellular carcinoma patients
por: Wei, Hongtao, et al.
Publicado: (2017)

Involvement of the NADPH oxidase 2 pathway in renal oxidative stress in Aqp11(-/-) mice
por: Hoshino, Yuya, et al.
Publicado: (2019)

Potential Clinical Implications of the Urotensin II Receptor Antagonists
por: Tsoukas, Philip, et al.
Publicado: (2011)

Urotensin-II: More Than a Mediator for Kidney
por: Balat, Ayşe, et al.
Publicado: (2012)

Blockade of Urotensin II Receptor Prevents Vascular Dysfunction
por: Kim, Young-Ae, et al.
Publicado: (2016)

Role of Urotensin-II in Saphenous Vein Graft Disease
por: Tüysüz, Mehmet Erin, et al.
Publicado: (2020)

Urotensin II levels in patients with inflammatory bowel disease
por: Alicic, Damir, et al.
Publicado: (2021)

Oscillatory shear stress promotes vein graft intimal hyperplasia via NADPH oxidase-related pathways
por: Yao, Guoqing, et al.
Publicado: (2023)

Urotensin II Protects Cardiomyocytes from Apoptosis Induced by Oxidative Stress through the CSE/H(2)S Pathway
por: Gong, Hui, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_qsgkk5marb0eop2hogvek6imuh